Insider Transactions Reported by 23 Insiders of Traws Pharma, Inc.

Symbol
TRAW on Nasdaq
Location
Newtown, PA

There are no Buy or Sell transactions made by insiders since 18 Mar 2025

Traws Pharma, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Viriom, Inc. 10%+ Owner $1,480,590 03 Apr 2024
Iain D. Dukes Chief Executive Officer, Director $438,092 08 Mar 2026
Nikolay Savchuk Chief Operating Officer, Director $385,551 08 Mar 2026
Charles D. Pauza Chief Science Officer Virology $296,885 08 Mar 2026
Robert Redfield Chief Medical Officer $291,632 08 Mar 2026
ORBIMED ADVISORS LLC 10%+ Owner $282,940 29 Dec 2024
Werner Cautreels Director $279,608 08 Mar 2026
Steven M. Fruchtman PRESIDENT, CHIEF EXECUTIVE OFF, Director $98,282 13 Mar 2024
Abraham N. Oler SVP Corp Dev & Gen Counsel $36,818 07 Feb 2022
Mark Patrick Guerin Chief Financial Officer $23,400 05 Feb 2025
Mary Teresa Shoemaker Director $16,107 08 Mar 2026
Jack E. Stover Director $15,782 08 Mar 2026
Trafford Clarke Director $15,761 08 Mar 2026
Mark S. Gelder MD Chief Medical Officer $13,847 13 Mar 2023
John H. Leaman Director $10,388 08 Mar 2026
TPAV, LLC 10%+ Owner $0 02 Apr 2025
James J. Marino Director 10 Aug 2023
Peter Atadja Director 10 Aug 2023
Jerome Groopman Director 10 Aug 2023
Victor M. Moyo Chief Medical Officer 02 Oct 2023
Viren Mehta Director 10 Aug 2023
Luba Greenwood Director 16 Sep 2024
Nora Brennan Interim CFO 05 Feb 2025

Recent Insider Transactions by Companies or Individuals for Traws Pharma, Inc.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Trafford Clarke TRAW Stock Option (right to buy) Award 33,435 33,435 08 Mar 2026 Direct
Werner Cautreels TRAW Stock Option (right to buy) Award 31,258 31,258 08 Mar 2026 Direct
John H. Leaman TRAW Stock Option (right to buy) Award 33,435 33,435 08 Mar 2026 Direct
Iain D. Dukes TRAW Stock Option (right to buy) Award 231,336 231,336 08 Mar 2026 Direct
Charles D. Pauza TRAW Stock Option (right to buy) Award 118,367 118,367 08 Mar 2026 Direct
Nikolay Savchuk TRAW Stock Option (right to buy) Award 96,899 96,899 08 Mar 2026 Direct
Jack E. Stover TRAW Stock Option (right to buy) Award 33,435 33,435 08 Mar 2026 Direct
Robert Redfield TRAW Stock Option (right to buy) Award 108,854 108,854 08 Mar 2026 Direct
Mary Teresa Shoemaker TRAW Stock Option (right to buy) Award 33,435 33,435 08 Mar 2026 Direct
John Harold Leaman TRAW Common Stock Award 4,058 4,058 12 Dec 2025 Direct
John Harold Leaman TRAW Stock Option (right to purchase) Award 16,234 16,234 12 Dec 2025 Direct
Trafford Clarke TRAW Common Stock Award 6,157 6,157 12 Dec 2025 Direct
Trafford Clarke TRAW Stock Option (right to purchase) Award 24,629 24,629 12 Dec 2025 Direct
Werner Cautreels TRAW Common Stock Award 4.67% 4,874 109,222 12 Dec 2025 Direct
Werner Cautreels TRAW Stock Option (right to purchase) Award 19,496 19,496 12 Dec 2025 Direct
Mary Teresa Shoemaker TRAW Common Stock Award 4560.7% 6,157 6,292 12 Dec 2025 Direct
Mary Teresa Shoemaker TRAW Stock Option (right to purchase) Award 24,629 24,629 12 Dec 2025 Direct
Jack E. Stover TRAW Common Stock Award 76962.5% 6,157 6,165 12 Dec 2025 Direct
Jack E. Stover TRAW Stock Option (right to purchase) Award 24,629 24,629 12 Dec 2025 Direct
Iain D. Dukes TRAW Common Stock Award 27.5% 36,943 171,130 12 Dec 2025 Direct
Iain D. Dukes TRAW Stock Option (right to purchase) Award 147,771 147,771 12 Dec 2025 Direct
Charles David Pauza TRAW Common Stock Award 18.9% 18,471 115,971 12 Dec 2025 Direct
Charles David Pauza TRAW Stock Option (right to purchase) Award 73,886 73,886 12 Dec 2025 Direct
Robert Redfield TRAW Common Stock Award 16.8% 16,419 113,919 12 Dec 2025 Direct
Robert Redfield TRAW Stock Option (right to purchase) Award 65,676 65,676 12 Dec 2025 Direct
Nikolay Savchuk TRAW Common Stock Award 12.2% 16,419 150,606 12 Dec 2025 Direct
Nikolay Savchuk TRAW Stock Option (right to purchase) Award 65,676 65,676 12 Dec 2025 Direct
John Harold Leaman TRAW Stock Option (right to purchase) Award 12,770 12,770 21 Nov 2025 Direct
Nikolay Savchuk TRAW Stock Option (right to purchase) Award 22,435 22,435 12 Oct 2025 Direct
Robert Redfield TRAW Stock Option (right to purchase) Award 32,406 32,406 12 Oct 2025 Direct
Charles David Pauza TRAW Stock Option (right to purchase) Award 32,406 32,406 12 Oct 2025 Direct
Iain D. Dukes TRAW Stock Option (right to purchase) Award 64,839 64,839 12 Oct 2025 Direct
Werner Cautreels TRAW Stock Option (right to purchase) Award 11,530 11,530 12 Oct 2025 Direct
Jack E. Stover TRAW Stock Option (right to purchase) Award 11,530 11,530 12 Oct 2025 Direct
Trafford Clarke TRAW Stock Option (right to purchase) Award 11,530 11,530 12 Oct 2025 Direct
Mary Teresa Shoemaker TRAW Stock Option (right to purchase) Award 11,530 11,530 12 Oct 2025 Direct
John Harold Leaman TRAW Stock Option (right to purchase) Award 15,609 15,609 01 Oct 2025 Direct
Trafford Clarke TRAW Stock Option (right to purchase) Award 23,000 23,000 19 Jun 2025 Direct
Jack E. Stover TRAW Stock Option (right to purchase) Award 23,000 23,000 19 Jun 2025 Direct
Mary Teresa Shoemaker TRAW Stock Option (right to purchase) Award 23,000 23,000 19 Jun 2025 Direct
Werner Cautreels TRAW Stock Option (right to purchase) Award 23,000 23,000 19 Jun 2025 Direct
Tpav, Llc TRAW Common Stock Other -100% -605,531 0 02 Apr 2025 Direct
Tpav, Llc TRAW Series C Preferred Stock Other -100% -2,264 0 02 Apr 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.